Healthcare · Active clinical trials
In 2026, Uzbekistan recorded zero active clinical trials (8 units), ranking 83 out of 197 countries. The lack of research infrastructure, weak integration into international pharmaceutical networks, and bureaucratic hurdles hinder clinical research. However, Uzbekistan holds significant potential: a large population, genetic diversity, and growing interest from foreign pharma companies in the Central Asian market could change the situation in the coming years, particularly in oncology and infectious diseases.
Data for 2026 · unit: units
Position
#83 / 197
Uzbekistan world ranking
Country position on the scale from last to first place for this indicator.
UZ
#83
#197#1
Trend
Change over time
Change in indicator over the available period.
5
1990
10
2000
1
2010
5
2020
10
2025
8
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Uzbekistan stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Uzbekistan — how much?
Based on 2026 data — 8 units. This is rank #83 out of 197 countries.
What is Uzbekistan's rank by Active clinical trials?
Uzbekistan ranks #83 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Uzbekistan?
Over the available period the indicator changed from 5 to 8 units.